{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:53:09Z","timestamp":1762955589303,"version":"3.37.3"},"reference-count":29,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2016]]},"DOI":"10.5582\/bst.2016.01008","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T18:05:54Z","timestamp":1463076354000},"page":"307-314","source":"Crossref","is-referenced-by-count":4,"title":["The preliminary clinical observation and analysis of childbearingage women with a history of iodine-131 treatment for Graves' disease"],"prefix":"10.5582","volume":"10","author":[{"given":"Liang","family":"Guan","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University"},{"name":"Department of Nuclear Medicine, Ruijin Hospital North, School of Medicine, Shanghai Jiaotong University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University"},{"name":"Department of Nuclear Medicine, Ruijin Hospital North, School of Medicine, Shanghai Jiaotong University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiali","family":"Zhang","sequence":"additional","affiliation":[{"name":"Laboratory for Reproductive Immunology, Hospital & Institute of Obstetrics and Gynecology, IBS, Shanghai Medical College, Fudan University"},{"name":"The Academy of Intergrative Medicine of Fudan University"},{"name":"Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[{"name":"Laboratory for Reproductive Immunology, Hospital & Institute of Obstetrics and Gynecology, IBS, Shanghai Medical College, Fudan University"},{"name":"The Academy of Intergrative Medicine of Fudan University"},{"name":"Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F, Young ET. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995; 43:55-68.","DOI":"10.1111\/j.1365-2265.1995.tb01894.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Liu M, Jing D, Hu J, Yin S. Predictive factors of outcomes in personalized radioactive iodine (<sup>131<\/sup>I) treatment for Graves&apos; disease. Am J Med Sci. 2014; 348:288-293.","DOI":"10.1097\/MAJ.0000000000000288"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Solomon B, Glinoer D, Lagasse R, Wartofsky L. Current trends in the management of Graves&apos; disease. J Clin Endocrinol Metab. 1990; 70:1518-1524.","DOI":"10.1210\/jcem-70-6-1518"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Muldoon BT, Mai VQ, Burch HB. Management of Graves&apos; disease: An overview and comparison of clinical practice guidelines with actual practice trends. Endocrinol Metab Clin North Am. 2014; 43:495-516.","DOI":"10.1016\/j.ecl.2014.02.001"},{"key":"5","unstructured":"5. Cruz Junior AF, Takahashi MH, Albino CC. Clinical treatment with anti-thyroid drugs or iodine-131 therapy to control the hyperthyroidism of Graves disease: A cost-effectiveness analysis. Arq Bras Endocrinol Metabol. 2006; 50:1096-1101."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hyer S, Kong A, Pratt B, Harmer C. Salivary gland toxicity after radioiodine therapy for thyroid cancer. Clin Oncol (R Coll Radiol). 2007; 19:83-86.","DOI":"10.1016\/j.clon.2006.11.005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hyer SL, Newbold K, Harmer CL. Early and late toxicity of radioiodine therapy: detection and management. Endocr Pract. 2010; 16:1064-1070.","DOI":"10.4158\/EP10170.RA"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sioka C, Zouboulidis A, Fotopoulos A, Dimakopoulos N. Re: risk of second primary malignancies in women with papillary thyroid cancer. Am J Epidemiol. 2007; 165:473; author reply 474.","DOI":"10.1093\/aje\/kwk097"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hyer S, Vini L, O&apos;Connell M, Pratt B, Harmer C. Testicular dose and fertility in men following I(131) therapy for thyroid cancer. Clin Endocrinol (Oxf). 2002; 56:755-758.","DOI":"10.1046\/j.1365-2265.2002.t01-1-01545.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wichers M, Benz E, Palmedo H, Biersack HJ, Grunwald F, Klingmuller D. Testicular function after radioiodine therapy for thyroid carcinoma. Eur J Nucl Med. 2000; 27:503-507.","DOI":"10.1007\/s002590050535"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ceccarelli C, Bencivelli W, Morciano D, Pinchera A, Pacini F. 131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: Results of a retrospective study. J Clin Endocrinol Metab. 2001; 86:3512-3515.","DOI":"10.1210\/jcem.86.8.7719"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sioka C, Kouraklis G, Zafirakis A, Manetou A, Dimakopoulos N. Menstrual cycle disorders after therapy with iodine-131. Fertil Steril. 2006; 86: 625-628.","DOI":"10.1016\/j.fertnstert.2006.02.081"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Franklyn JA, and Boelaert K. Thyrotoxicosis. Lancet. 2012; 379:1155-1166.","DOI":"10.1016\/S0140-6736(11)60782-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Georgiou HM, Di Quinzio MK, Permezel M, Brennecke SP. Predicting Preterm Labour: Current Status and Future Prospects. Dis Markers. 2015; 2015: 435014.","DOI":"10.1155\/2015\/435014"},{"key":"15","unstructured":"15. Yang M, Wang J, QIAN B, Dai J, Zhang X, Chen A, Meng Y. Monitoring and analysis of birth defects in 73498 infants. Journal of Clinical Pediatrics. 2015; 6:553-557. (in Chinese)"},{"key":"16","unstructured":"16. Zhang L, Liu KB, Pan Y, Zhang QL. Global progress in stillbirth study. Chinese Journal of Woman and Child Health Research. 2015; 26: 896-898. (in Chinese)"},{"key":"17","unstructured":"17. Dottorini ME, Lomuscio G, Mazzucchelli L, Vignati A, Colombo L. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med. 1995; 36:21-27."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sioka C, Fotopoulos A. Effects of I-131 therapy on gonads and pregnancy outcome in patients with thyroid cancer. Fertil Steril. 2011; 95:1552-1559.","DOI":"10.1016\/j.fertnstert.2011.01.017"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Silberstein EB, Alavi A, Balon HR, Clarke SE, Divgi C, Gelfand MJ, Goldsmith SJ, Jadvar H, Marcus CS, Martin WH, Parker JA, Royal HD, Sarkar SD, Stabin M, Waxman AD. The SNMMI practice guideline for therapy of thyroid disease with <sup>131<\/sup>I 3.0. J Nucl Med. 2012; 53:1633-1651.","DOI":"10.2967\/jnumed.112.105148"},{"key":"20","unstructured":"20. Hyer S, Pratt B, Newbold K, Hamer C. Outcome of pregnancy after exposure to radioiodine In utero. Endocr Pract. 2011; 1-10. doi: http:\/\/dx.doi.org\/10.4158\/EP10237. RA"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. American Thyroid Association Taskforce On Radioiodine S, Sisson JC, Freitas J, McDougall IR, Dauer LT, Hurley JR, Brierley JD, Edinboro CH, Rosenthal D, Thomas MJ, Wexler JA, Asamoah E, Avram AM, Milas M, Greenlee C. Radiation safety in the treatment of patients with thyroid diseases by radioiodine <sup>131<\/sup>I: Practice recommendations of the American Thyroid Association. Thyroid. 2011; 21:335-346.","DOI":"10.1089\/thy.2010.0403"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Garsi JP, Schlumberger M, Rubino C, Ricard M, Labbe M, Ceccarelli C, Schvartz C, Henri-Amar M, Bardet S, de Vathaire F. Therapeutic administration of <sup>131<\/sup>I for differentiated thyroid cancer: Radiation dose to ovaries and outcome of pregnancies. J Nucl Med. 2008; 49:845-852.","DOI":"10.2967\/jnumed.107.046599"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. do Ros\u00e1rio PW, Barroso AL, Rezende LL, Padr\u00e3o EL, Borges MA, Purisch S. Malformations in the offspring of women with thyroid cancer treated with radioiodine for the ablation of thyroid remnants. Arq Bras Endocrinol Metabol. 2006; 50:930-933.","DOI":"10.1590\/S0004-27302006000500016"},{"key":"24","unstructured":"24. Balenovic A, Vlasic M, Sonicki Z, Bodor D, and Kusic Z. Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma. Coll Antropol. 2006; 30:743-748."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Bal C, Kumar A, Tripathi M, Chandrashekar N, Phom H, Murali NR, Chandra P, Pant GS. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring. Int J Radiat Oncol Biol Phys. 2005; 63:449-455.","DOI":"10.1016\/j.ijrobp.2005.02.043"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Brandao CD, Miranda AE, Correa ND, Sieiro Netto L, Corbo R, Vaisman M. Radioiodine therapy and subsequent pregnancy. Arq Bras Endocrinol Metabol. 2007; 51:534-540.","DOI":"10.1590\/S0004-27302007000400006"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Fard-Esfahani A, Mirshekarpour H, Fallahi B, Eftekhari M, Saghari M, Beiki D, Ansari-Gilani K, Takavar A. The effect of high-dose radioiodine treatment on lacrimal gland function in patients with differentiated thyroid carcinoma. Clin Nucl Med. 2007; 32:696-699.","DOI":"10.1097\/RLU.0b013e318124fdb6"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Vini L, Hyer S, Al-Saadi A, Pratt B, Harmer C. Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer. Postgrad Med J. 2002; 78:92-93.","DOI":"10.1136\/pmj.78.916.92"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Chow SM, Yau S, Lee SH, Leung WM, Law SC. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: No deleterious effect after radioactive iodine treatment. Int J Radiat Oncol Biol Phys. 2004; 59:992-1000.","DOI":"10.1016\/j.ijrobp.2003.12.023"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/10\/4\/10_2016.01008\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T09:34:25Z","timestamp":1498296865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/10\/4\/10_2016.01008\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2016.01008","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"type":"print","value":"1881-7815"},{"type":"electronic","value":"1881-7823"}],"subject":[],"published":{"date-parts":[[2016]]}}}